A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune Systems

NCT00002315 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Glaxo Wellcome